Zoth Lota S.
- SEC CIK
- 0001278219
No open-market purchases or sales filed in the past year.
Current role at each company
- ENGN enGene Therapeutics Inc.Directoras of Jun 17, 2026
- INO Inovio Pharmaceuticals, Inc.Directoras of May 21, 2026
- FFIN First Financial Bankshares IncDirectoras of May 5, 2026
- ETNB 89bio, Inc.Directoras of Oct 30, 2025
- LUMO Lumos Pharma, Inc.Directoras of Dec 13, 2024
Show 1 more company
- ZYME Zymeworks Inc.Directoras of Dec 23, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Zoth Lota S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INO Inovio Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 (view filing) | Jun 5 | Same day | Zoth Lota S.Director | SSale | −5.70K | $0.56 | −$3.19K | −9.8%52.7K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Zoth Lota S.Director | SSale | −3.60K | $1.98 | −$7.13K | −8.4%39.4K after | |
| Jan 5, 2022 (view filing) | Jan 5 | Same day | Zoth Lota S.Director | SSale | −961 | $5.01 | −$4.81K | −3.7%25.0K after |